Downregulation of NUAK1 Does Not Sensitize SOC to Cisplatin or Paclitaxel, but Does Attenuate the Migratory Potential of Chemosensitive and Resistant Ovarian Cancer Cells In Vitro. The gene discussed is NUAK1; the disease is ovarian cancer.